Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical Application of Breast Blood-oxygen Functional Imaging Technology

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01678170
Recruitment Status : Unknown
Verified May 2012 by Tianjin Medical University Cancer Institute and Hospital.
Recruitment status was:  Recruiting
First Posted : September 3, 2012
Last Update Posted : December 22, 2015
Sponsor:
Information provided by (Responsible Party):
Tianjin Medical University Cancer Institute and Hospital

Brief Summary:
This trial is going to evaluate the value of blood-oxygen functional imaging technology in the diagnosis of breast diseases.

Condition or disease
Breast Diseases

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Clinical Application of Breast Blood-oxygen Functional Imaging Technology
Study Start Date : September 2012
Estimated Primary Completion Date : November 2016
Estimated Study Completion Date : December 2016

Resource links provided by the National Library of Medicine






Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Female with breast lump, received breast ultrasound and mammography
Criteria

Inclusion Criteria:

  • female older than 18 years breast lump received breast ultrasound and mammography

Exclusion Criteria:

  • After core-needle biopsy or resection After neoadjuvant chemotherapy, radiotherapy or endocrine therapy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678170


Contacts
Layout table for location contacts
Contact: Peifang Liu, M.D. +86-22-23524536 cjr.liupeifang@vip.163.com

Locations
Layout table for location information
China, Tianjin
Department of Breast Imaging, Tianjin Medical University Cancer Hospital Recruiting
Tianjin, Tianjin, China, 300060
Contact: Peifang Liu, M.D.    +86-22-23524536    cjr.liupeifang@vip.163.com   
Sponsors and Collaborators
Tianjin Medical University Cancer Institute and Hospital
Investigators
Layout table for investigator information
Principal Investigator: Peifang Liu, M.D. Department of Breast Imaging, Tianjin Medical University Cancer Hospital

Layout table for additonal information
Responsible Party: Tianjin Medical University Cancer Institute and Hospital
ClinicalTrials.gov Identifier: NCT01678170    
Other Study ID Numbers: CIH-LPF-201205001
First Posted: September 3, 2012    Key Record Dates
Last Update Posted: December 22, 2015
Last Verified: May 2012
Keywords provided by Tianjin Medical University Cancer Institute and Hospital:
blood-oxygen functional imaging technology
diagnosis
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Diseases
Skin Diseases